You haven't searched anything yet.
The Senior Director, Regulatory Affairs - GDP provides strategic oversight and direction for regulatory activities on a regional and/or global scale. This role entails leading a multidisciplinary team in developing and executing regulatory strategies to advance our vaccine and bacterial product portfolio through all stages of development and commercialization within specific regions, such as the US. Responsibilities include developing and implementing regulatory strategy, driving regulatory submissions, fostering collaboration with regional regulatory authorities, managing regulatory risks and opportunities, and providing strategic guidance to executive and senior leadership. The Senior Director will serve as a key advisor on regulatory matters, ensuring alignment with company goals, regional requirements, and best practices to achieve successful outcomes for our products in targeted markets.
RESPONSIBILITIES
MINIMUM JOB REQUIREMENTS
Qualifications
Competencies
Other Requirements
ESSENTIAL PHYSICAL REQUIREMENTS
To be considered for this position, you must apply and meet the requirements of this opportunity. We look forward to reviewing your resume & qualifications.
Disclaimer
The job description is not designed to cover or contain a comprehensive listing of requirements, duties or responsibilities that are required of the employee. Other requirements, duties and responsibilities may change or be assigned at any time with or without notice.
You acknowledge and agree that information described herein may be disclosed to applicable regulatory authorities, alliance partners and/or third-party service providers as necessary for Shionogi to fulfil its obligations under applicable laws, including but not limited to compliance with regulatory inspections and/or audits.
EEO Statement
Shionogi Inc. is an equal opportunity/affirmative action employer.
All qualified applicants will receive equal consideration for employment opportunities based on valid job requirements without regard to race, color, religion, sex (including pregnancy), sexual orientation, gender identity, marital status, national origin, age, ancestry, citizenship, disability, genetic information, status as a disabled veteran, a recently separated veteran, Active Duty Wartime or Campaign Badge Veterans, and Armed Forces Service Medal Veterans, or any other characteristic protected by applicable law.
It is the policy of Shionogi Inc. to undertake affirmative action in compliance with all federal, state, and local requirements to recruit a diverse pool of applicants and to ensure that our employment practices are, in fact, non-discriminatory.
Full Time
Pharmaceutical
$182k-241k (estimate)
04/25/2024
06/23/2024
shionogi.com
ALPHARETTA, GA
200 - 500
2001
TADASHI HARA
$50M - $200M
Pharmaceutical
About Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease. Its Time to Revolutionize Medicine Again More than 23,000 men, women and children in the U.S. die every year from antibiotic-resistant infections while over 4,000 Americans peri...sh from influenza. In addition, over 100 million suffer from chronic pain and 3.9 million adults in the U.S. are diagnosed with liver disease. Shionogis mission is to supply the best possible medicines to protect the health and well-being of the patients we serve. With over 50 years of anti-infective research experience, Shionogi has helped to revolutionize the development of antibacterial and antiviral treatments. As bacteria, pathogens and other viruses adapt to resist existing treatmentscausing millions of untreatable infections around the worldShionogi is pursuing the development of novel treatments to combat this evolving threat. Shionogi, both itself and through innovative alliances, is also pursuing the development of new treatments in other areas of high medical need, including inflammatory pain, neuropathic pain, Alzheimers disease and ADHD. At Shionogi Inc., were intensely focused on developing and commercializing the scientific breakthroughs emerging from our research laboratories in Japan as well as discoveries of our strategic alliance partners. We couple our innovative discovery base with capabilities to advance drug candidates rapidly from lab to clinic to patient, forming, where appropriate, bold new partnerships to accelerate and amplify the availability of these new medications to patients around the world.
More
Show less